HMN 214
Alternative Names: IDEC 160; IVX-214; TV 7101 - Teva; TV-7101Latest Information Update: 24 May 2010
Price :
$50 *
At a glance
- Originator Nippon Shinyaku
- Class Antineoplastics; Small molecules; Sulfonamides
- Mechanism of Action Cyclin-dependent kinase inhibitors; Polo-like kinase 1 inhibitors; Transcription factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Solid tumours
Most Recent Events
- 24 May 2010 Discontinued - Phase-I for Solid tumours in Japan (PO)
- 24 May 2010 Discontinued - Phase-I for Solid tumours in USA (PO)
- 16 Mar 2007 Teva Pharmaceuticals terminates its licence for HMN 214